DaBomb Protein Biotech Corp.
6578
Rank in Stocks
#23949
DaBomb Protein Biotech Corp. is a specialized biotechnology enterprise... DaBomb Protein Biotech Corp. is a specialized biotechnology enterprise primarily dedicated to developing and commercializing antibiotic replacements for the animal health industry. Its extensive product range includes plant-based proteins such as DaBomb-P (Aqua) and DaBomb-P (Livestock), alongside specific antibiotic alternative solutions like DBT-100 HT and DBT-100 LS. The company also manufactures pet care products, featuring LACTOTIDES HEALTH A+ and Liqui-TIDE bandages. Founded in 2001 and headquartered in Tainan, Taiwan, the firm adopted its current name, DaBomb Protein Biotech Corp., in October 2023, having previously operated as DaBomb Protein Corp.
Share Price
$0.5182358
Last synced: 2026-11-10
Market Cap
$37.28M
Change (1 day)
0.59%
Change (1 year)
-19.49%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade DaBomb Protein Biotech Corp. (6578)
Category
Consumer Defensive
Operating Margin for DaBomb Protein Biotech Corp. (6578)
Operating Margin as of November 2026 TTM: -6.34%
According to DaBomb Protein Biotech Corp.'s latest financial reports, its current operating margin (TTM) is -6.34%. At the end of 2025 the company had an operating margin of -9.11%.
Operating Margin history for DaBomb Protein Biotech Corp. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -6.34% | -30.41% |
| 2025 | -9.11% | 1,587.04% |
| 2024 | -0.54% | -93.07% |
| 2023 | -7.79% | -20.51% |
| 2022 | -9.80% | -31.18% |
| 2021 | -14.24% | -705.96% |
| 2020 | 2.35% | -61.16% |
| 2019 | 6.05% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 14.06% | -102.22% |
CH
|
|
| 11.72% | -101.85% |
FR
|
|
| 5.67% | -100.89% |
BR
|
|
| 9.43% | -101.49% |
CN
|
|
| 26.85% | -104.24% |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about DaBomb Protein Biotech Corp.'s operating margin
What is DaBomb Protein Biotech Corp.'s operating margin?
DaBomb Protein Biotech Corp.'s operating margin is -6.34%, as of Nov 2026.
What was DaBomb Protein Biotech Corp.'s operating margin in 2025?
In 2025, DaBomb Protein Biotech Corp.'s operating margin was -9.11%, compared with -0.54% in 2024.
How has DaBomb Protein Biotech Corp.'s operating margin changed since 2020?
From 2020 to 2025, DaBomb Protein Biotech Corp.'s operating margin was highest in 2020 (2.35%) and lowest in 2021 (-14.24%).
How does DaBomb Protein Biotech Corp.'s operating margin compare with similar companies?
DaBomb Protein Biotech Corp.'s operating margin (-6.34%) is lower than that of all 5 similar companies listed above. The highest among them is Foshan Haitian Flavouring and Food Company Ltd., with 26.85%.